Building the Future of Medicine
BioSpectrum Asia|BioSpectrum Asia Jan 2025
PRODUCT OF THE YEAR 2024 - Needle Free Injection System technology by IntegriMedical
Building the Future of Medicine

Founded in 2020, IntegriMedical embarked on a mission to revolutionise healthcare by tackling one of the most persistent challenges- the fear of needles and the discomfort of traditional injections. Guided by a shared vision, Scott McFarland, Ankur Naik, Sarvesh Mutha, and Mark Timm combined over two decades of unparalleled expertise in medical device innovation to pioneer the revolutionary NeedleFree Injection System (N-FIS).

At the forefront of innovation, the ergonomically designed N-FIS leverages cutting-edge jetinjection technology to eliminate needles, delivering medications with precision while drastically reducing pain and discomfort. This breakthrough innovation underscores IntegriMedical's steadfast commitment to patient-centric care and transformative healthcare solutions.

Sarvesh Mutha, Managing Director, IntegriMedical highlights, "Every challenge presents an opportunity for innovation. At IntegriMedical, we've embraced these obstacles to create a technology that not only addresses pain points but transforms how injections are perceived and delivered."

With state-of-the-art research and manufacturing facilities across USA, India, Hong Kong & Hungary, IntegriMedical seamlessly integrates global expertise with in-house operations to uphold the highest standards of quality, regulatory and adaptability. As a trailblazer in drug-delivery innovation, the company continues to redefine patient care, driving exceptional outcomes and shaping the future of healthcare on a global scale.

Tackling Key Challenges

هذه القصة مأخوذة من طبعة BioSpectrum Asia Jan 2025 من BioSpectrum Asia.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة BioSpectrum Asia Jan 2025 من BioSpectrum Asia.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من BIOSPECTRUM ASIA مشاهدة الكل
"We are dedicated to helping people of all ages see brilliantly"
BioSpectrum Asia

"We are dedicated to helping people of all ages see brilliantly"

The global leader in eye care for over 75 years, Alcon Inc. strives to help eye care professionals strengthen their practices and serve patients better, improving visual health worldwide. Through its innovative eye care portfolios, Alcon has established operations in 56 countries and serves patients in 140 countries. Jason Hoffe, Vice President, APAC Vision Care, Alcon, responsible for driving the vision care business in the region shares opportunities exist for the company and new developments in eye healthcare that are cause for optimism for patients in the region.

time-read
5 mins  |
BioSpectrum Asia Jan 2025
Singapore Turns Tech Beacon with Revolutionary Pharma Manufacturing & Digital Transformation
BioSpectrum Asia

Singapore Turns Tech Beacon with Revolutionary Pharma Manufacturing & Digital Transformation

In the current pharmaceutical manufacturing environment, linking information technology (IT) with operational technology (OT) systems is increasingly vital. This integration enables a seamless exchange of information between these two historically separate domains - one focused on data management and the other on overseeing physical operations. This enables various aspects of the manufacturing process to gain insights from one another to boost efficiency and refine strategic decision-making. Digital transformation is essential for directing companies through the complexities of implementation and ensuring a seamless shift to a data-driven, digitally optimized manufacturing landscape.

time-read
6 mins  |
BioSpectrum Asia Jan 2025
Building the Future of Medicine
BioSpectrum Asia

Building the Future of Medicine

PRODUCT OF THE YEAR 2024 - Needle Free Injection System technology by IntegriMedical

time-read
4 mins  |
BioSpectrum Asia Jan 2025
Emerging Leader in Cell & Gene Therapy
BioSpectrum Asia

Emerging Leader in Cell & Gene Therapy

STARTUP OF THE YEAR 2024 - ImmunoACT

time-read
3 mins  |
BioSpectrum Asia Jan 2025
Improving Access for Respiratory Healthcare
BioSpectrum Asia

Improving Access for Respiratory Healthcare

STARTUP OF THE YEAR 2024 - Aevice Health

time-read
4 mins  |
BioSpectrum Asia Jan 2025
Making an Impact with a 'CliKX'
BioSpectrum Asia

Making an Impact with a 'CliKX'

Dr Lynne Lim, Co-Founder & Chief Executive Officer, NousQ

time-read
4 mins  |
BioSpectrum Asia Jan 2025
Eyeing 20-20 Vision of Excellence
BioSpectrum Asia

Eyeing 20-20 Vision of Excellence

Dr Jogin Desai, Co-Founder & Chief Executive Officer, Eyestem Research

time-read
4 mins  |
BioSpectrum Asia Jan 2025
Refining the Use of Radiation
BioSpectrum Asia

Refining the Use of Radiation

Dr Christian Behrenbruch, Managing Director and Group Chief Executive Officer (CEO), Telix Pharmaceuticals

time-read
3 mins  |
BioSpectrum Asia Jan 2025
Honouring Innovators in Asia's Thriving Life Sciences Sector
BioSpectrum Asia

Honouring Innovators in Asia's Thriving Life Sciences Sector

Asia has, indeed, become the new hub for growth and innovation, with no signs of losing steam. To recognise the Asian companies and individuals for their commendable performance and achievements during 2023 and 2024, BioSpectrum Asia Excellence Awards 2024 ceremony was held at Hotel Fort Canning in Singapore on December 6, 2024.

time-read
2 mins  |
BioSpectrum Asia Jan 2025
How To Control Indian Diabetes Growth
BioSpectrum Asia

How To Control Indian Diabetes Growth

World Diabetes Day, observed on November 14, reminds us of the growing impact of diabetes on global health and the urgent need for collective action to prevent, diagnose, and manage this chronic condition. In 2024, the theme 'Breaking Barriers, Bridging Gaps' underscores the critical importance of accessible, high-quality diabetes care, especially for underrepresented communities. The Government of India has taken many measures intending to reduce the prevalence of diabetes and alleviate its long-term complications, contributing to a healthier future for all citizens.

time-read
4 mins  |
December 2024